Exact Mass: 408.2412802
Exact Mass Matches: 408.2412802
Found 169 metabolites which its exact mass value is equals to given mass value 408.2412802,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lofentanilum
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
MG(PGJ2/0:0/0:0)
MG(PGJ2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/PGJ2/0:0)
MG(0:0/PGJ2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
[8]-Gingerdiol
[8]-gingerdiol is a member of the class of compounds known as fatty alcohol esters. Fatty alcohol esters are ester derivatives of a fatty alcohol. [8]-gingerdiol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). [8]-gingerdiol can be found in ginger, which makes [8]-gingerdiol a potential biomarker for the consumption of this food product.
(rel 5S,6R,8R,9R,10S,13S,16S)-6-acetoxy-9,13-epoxy-16-methoxy-labdan-15,16-olide
(3S,5S,8R,9R,10S,13S,16S)-3-acetoxy-9,13-epoxy-16-methoxylabdan-15,16-olide|negundoin D
Australifungin
A carbobicyclic compound that is 4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one substituted by hydroxy groups at positions 2, 5 and 8, a (2Z)-3-hydroxyprop-2-enoyl group at position 4, methyl groups at positions 4 and 7 and a 2R-octan-2-yl group at position 3 (the 4S,4aR,5S,7R,8R,8aS stereoisomer). It is isolated from the fermentation extracts of Sporormiella australis and exhibits antifungal activity by interfering with the fungal lipid metabolism.
(rel-5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-16-methoxy-13(14)-labden-15,16-olide|viteagnusin H
2-(2-acetoxytridecyl)-6-hydroxy-4-methoxybenzoic acid
12-Deoxy,2-Ac,4-Me ether-(2R,12S)-6-(2,12-Dihydroxytridecyl)-2,4-dihydroxybenzoic acid
methyl 6beta-hydroxy-18-acetoxy-grindelane methyl ester
dimethyl (14S)-(2E,6E,10Z)-6-methoxycarbonyl-2,10,14-trimethylhexadeca-2,6,10-trienedioate
(2R)-6-(2-acetoxytridecyl)-5-formyl-2-methoxy-1,4-dihydroxybenzene
(rel 5S,6R,8R,9R,10S,13S)-6-acetoxy-9,13-epoxy-15-methoxy-labdan-16,15-olide
ambiguine A|ambiguine A isonitrile
C26H33ClN2 (408.23321280000005)
(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide|(rel 5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide
C23H36O6_1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (betaR,deltaR,1S,2S,8S,8aR)
(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid_major
Pro Pro Pro Val
Pro Pro Val Pro
Pro Val Pro Pro
Val Pro Pro Pro
(3R,5R)-3,5-Dihydroxy-7-{(1S,2S,8S,8aR)-2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}heptanoic acid
Lofentanil
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
3,5-Dihydroxy-7-[2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid
[(8S,9R,10R)-9-[4-(1-cyclopentenyl)phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
ethyl 2,7,7-trimethyl-4-(1-methyl-3,4-dihydro-2H-quinolin-6-yl)-5-oxo-3,4,6,8-tetrahydroquinoline-3-carboxylate
[(E)-2-(butanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(propanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-acetamido-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(pentanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
lofentanyl
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
TG(20:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
CYM51010
CYM51010 is a biased ligand of μ-opioid receptor – δ-opioid receptor heterodimers with an EC50 of 403 nM. CYM51010 exhibits anti-nociceptive activity similar to morphine but with a decreased levels of tolerance development and withdrawal symptoms[1].
methyl (1r,2s,5e)-2-[(2e,5s)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate
(1e,5e)-1-[6-(2,3-dihydroxy-3-methylbutyl)-3-hydroxy-2-(hydroxymethyl)phenyl]undeca-1,5-diene-3,4-diol
3-[(2e)-7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl]-2,4-dihydroxy-6-methylbenzoic acid
5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate
4-hydroxy-4-[2-(2-methoxy-5-oxo-2h-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
methyl 2-[(1r,3s,4e,7e,11s,12r)-11-(acetyloxy)-3,12-dihydroxy-4,8,12-trimethylcyclotetradeca-4,7-dien-1-yl]prop-2-enoate
asebotoxin ii
{"Ingredient_id": "HBIN017047","Ingredient_name": "asebotoxin ii","Alias": "NA","Ingredient_formula": "C23H36O6","Ingredient_Smile": "CCC(=O)OC1C2CCC3C1(CC(C4(C(C3=C)CC(C4(C)C)O)O)O)CC2(C)O","Ingredient_weight": "408.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1849","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "135876151","DrugBank_id": "NA"}
1-(2-formyl-3,6-dihydroxy-5-methoxyphenyl)tridecan-2-yl acetate
(1s,2s,2''s,4s,4ar,5'r,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate
(1s,4ar,5r,8as)-5-[(3r)-1-[(3-carboxypropanoyl)oxy]pentan-3-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
3-{[(4ar,5s,6r,8ar)-5-{2-[(3r,5s)-5-hydroxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}-3-oxopropanoic acid
(1r,2r,2''s,4as,5's,6s,8as)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate
5-{1-[(3-carboxypropanoyl)oxy]pentan-3-yl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
(1s,2s,5r,10r,11r,12r,14r,16r,17r)-12,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane-17-carboxylic acid
(3r,6e,10z,14e)-10-[(acetyloxy)methyl]-16-hydroxy-14-(hydroxymethyl)-3,6-dimethyl-2-methylidenehexadeca-6,10,14-trienoic acid
n-[5-chloro-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraen-3-yl]methanimine
C26H33ClN2 (408.23321280000005)
2-[2-(acetyloxy)tridecyl]-6-hydroxy-4-methoxybenzoic acid
[3-(2-methoxy-2-oxoethyl)-4a,7,7,10a-tetramethyl-2-oxo-octahydro-3h-naphtho[1,2-b]pyran-4-yl]methyl acetate
(1s,3s,4s,4ar,8ar)-4-hydroxy-4-{2-[(2r)-2-methoxy-5-oxo-2h-furan-3-yl]ethyl}-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
(5r,5as,9r,9ar,9bs)-9,9b-dihydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl octanoate
(1s,4r,4ar,5s,5'r,8ar)-4-hydroxy-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate
(1s,2s,2''r,4s,4ar,5's,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate
5-(2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl)-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one
(1s,3r,3's,3ar,4s,5r,7ar)-1-(acetyloxy)-3'-methyl-5-(1,3,3-trimethylcyclohexyl)-hexahydro-1h-spiro[2-benzofuran-4,2'-oxiran]-3-yl acetate
(1e,3s,4s,5e)-1-{6-[(2s)-2,3-dihydroxy-3-methylbutyl]-3-hydroxy-2-(hydroxymethyl)phenyl}undeca-1,5-diene-3,4-diol
methyl (2e)-5-[(1r,2r,4s,4ar,8ar)-2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-1,4a-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate
methyl (3r)-5-[(1r,2s,3s,4as,8ar)-3-(acetyloxy)-6-hydroxy-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoate
(3r,5s)-3-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)dodecan-5-yl acetate
methyl (1r,2s,5e)-2-[1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate
5''-methoxy-2,5,5,8a-tetramethyl-2''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate
(1r,3s,6r,8e,10r,13s,14s,16s)-3,6,14-trihydroxy-5,5,9,14-tetramethyl-4-oxotricyclo[11.2.1.0¹,¹⁰]hexadec-8-en-16-yl propanoate
(4s,4ar,5s,7r,8r,8as)-2,5,8-trihydroxy-4-(3-hydroxyprop-2-enoyl)-4,7-dimethyl-3-[(2r)-octan-2-yl]-4a,5,6,7,8,8a-hexahydronaphthalen-1-one
5-[(2r,5e,7e,9r,10r,11e)-2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl]-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one
n-[(2s,3r,4r,5r,7s)-5-chloro-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraen-3-yl]methanimine
C26H33ClN2 (408.23321280000005)